Innolake Biopharm

China
Hengyang, Hunan, China

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$60M
Last funding
Series A / $14.1M / 2023-06-05
Last equity funding
Series A / $14.1M
Investors
6
Articles
5

Founders and investors

Investors

CDH InvestmentsHangzhou Heda Industry FundHuagai CapitalWuXi BiologicsZhongbo Juli